Acute graft-versus-host disease (GVHD) is a complication of bone marrow transplantation (BMT). The histopathologic features used to diagnose GVHD are nonspecific, and may be secondary to chemotherapy or irradiation given before BMT. The presence of apoptotic keratinocytes or activated CTL may distinguish GVHD from conditioning effects. This study investigated the relationship in BMT recipients between keratinocyte apoptosis and the effects of conditioning regimens or immune-mediated GVHD. Inflammatory cells, apoptotic keratinocytes, and CTL expressing TIA-1 (a molecule associated with the lytic granules of CTL) were quantitated in allogeneic and autologous recipients. Allogeneic recipients could exhibit keratinocyte apoptosis secondary to a combination of conditioning effects and immune-mediated GVHD. In contrast, autologous recipients should show conditioning effects only. 'Capped' TIA-1-positive lymphocytes and apoptotic keratinocytes were much more frequent in the allogeneic group than the autologous group (16.1% of total TIA-1 positive lymphocytes vs 4.5%, P = 0.02; and 37.6/mm 2 vs 3.9/mm 2 , P = 0.005, respectively), although there was some overlap in their frequency. Among individual recipients of allogeneic BMT, the number of epidermal lymphocytes or macrophages correlated with the number of apoptotic keratinocytes. A similar, but weaker, correlation was seen between the number of 'capped' TIA-1-positive lymphocytes and apoptotic keratinocytes. No such relationship was seen in autologous recipients. In allogeneic recipients, TIA-1 expressing CTL were seen in intimate contact with apoptotic keratinocytes, some of which also had detectable cytoplasmic TIA-1. No CTL/keratinocyte interactions were identified in autologous recipients. Our results suggest that apoptotic keratinocytes arise in the skin of BMT patients due to both GVHD and conditioning effects, and that the keratinocyte damage in GVHD is mediated by both CTL-dependent and -independent mechanisms. Increased numbers of apoptotic keratinocytes, in the presence of increased epidermal lymphocytes or 'capped' TIA-1-expressing lymphocytes, support a diagnosis 
Acute graft-versus-host disease (GVHD) is a major cause of morbidity and mortality following bone marrow transplantation (BMT). It occurs in about one-half of patients undergoing allogeneic BMT, and is a contributory or primary cause of death in 15-40%. 1, 2 The target organs of acute GVHD are the skin, gastrointestinal tract and liver.
GVHD following BMT is thought to result from the transfer of immunocompetent cells from a donor to an MHC-mismatched recipient who is incapable of rejecting them. Originally, this was assumed to lead to a direct CTL attack on the recipient's target tissues. More recently, however, it has been suggested that the pathology of GVHD may instead be due to release of inflammatory cytokines (the so-called 'cytokine storm') which leads to direct tissue damage.
GVHD is treated most effectively when detected early. 2, 3 In most institutions, the primary diagnostic procedure for GVHD is the skin biopsy. In the skin, acute GVHD results in a lichenoid dermatitis, with mononuclear infiltration of the upper dermis and lower epidermis. In mild cases, this infiltration results in only mild vacuolar interface changes. As the damage becomes more severe, apoptotic death of individual keratinocytes occurs. In the most severe cases, apoptosis of confluent keratinocytes can result in bulla formation or sloughing of the epidermis. Unfortunately, these histopathologic features are not unique to GVHD. Other processes, including the total body irradiation or chemotherapy used as conditioning regimens for BMT, can cause pathology with similar appearance. Even in true GVHD, the histopathologic features do not differentiate between damage due to cytokine release, direct CTL attack, or some combination of the two. Among the various diagnostic criteria which have been used to differentiate conditioning effects from true GVHD, the time posttransplant is especially helpful, since conditioning effects are most pronounced in the first 20 days after transplant, while acute GVHD tends to occur somewhat later. 4, 5 However, there is considerable overlap in timing between the two processes, and additional distinguishing features would be useful.
Previous reports have suggested that the presence of either apoptotic keratinocytes 6, 7 or activated CTL 8 can be used to distinguish GVHD from the effects of pre-BMT conditioning. In a general sense, apoptosis, or programmed cell death, occurs in response to a variety of insults to cells. These insults could include the immune attack of GVHD (mediated by cytokines or CTL), and pre-BMT conditioning. Similarly, activated CTL could represent GVHD, but are also seen in drug reactions and autoimmune conditions. The purpose of this study was to investigate the relationship in BMT recipients between keratinocyte apoptosis and the effects of conditioning regimens or GVHD, mediated either by CTL or CTL-independent mechanisms. The presence of inflammatory cells, activated CTL, and apoptotic keratinocytes was determined in biopsies from patients after either allogeneic or autologous BMT. Allogeneic transplant patients could exhibit keratinocyte apoptosis secondary to the combined effects of conditioning regimens and immune-mediated GVHD. In contrast, most autologous transplant recipients would show only conditioning effects. A minority of these patients might also exhibit 'autologous GVHD'. We demonstrate here that while apoptotic keratinocytes can occur secondary to the immune attack of GVHD, they can also be seen without evidence of immune attack, most likely secondary to conditioning effects. Among cases with evidence of immune attack, both CTLdependent and -independent mechanisms appear to be operative. While increased numbers of apoptotic keratinocytes together with lymphocyte infiltration and 'capped' TIA-1-expressing lymphocytes support the diagnosis of GVHD, these findings must be interpreted in the context of clinical information and other histopathologic findings.
Materials and methods

Patients
Between 1988 and 1993, 223 BMT (165 allogeneic, 55 autologous, and three syngeneic) were performed at the Seattle Veterans Affairs Medical Center. Skin biopsies were performed on all autologous or allogeneic BMT patients with dermatologic eruptions lasting greater than 48 h. Eleven allogeneic and 12 autologous BMT recipients were chosen at random for this study. Some of the BMT recipients had more than one biopsy, for a total of 29 biopsies. Patient clinical data are listed in Table 1 .
Immunocytochemistry and TUNEL staining
Immunoperoxidase staining was performed on paraffinembedded sections, using standard techniques. 9 Monoclonal antibody TIA-1 (IgG1; Coulter Immunology, Hialeah, FL, USA) recognizes a 15 kDa component of the lytic granules of CTL and NK cells, and does not show reactivity with other hematopoietic 10 or non-hematopoietic cells. 
Diagnostic criteria and histopathologic analysis
Skin biopsies were evaluated using published diagnostic and grading criteria for acute GVHD: 12 grade 1, lichenoid mononuclear infiltration of the upper dermis and epidermis with vacuolation of basal cells; grade 2, more severe damage resulting in individual basal cell death (apoptosis); grade 3, coalescence of dead basal cells to produce clefts at the dermal-epidermal junction; and grade 4, sloughing of the epidermis. In addition, biopsies were quantitatively evaluated for the presence of lymphocytes, macrophages, apoptotic keratinocytes (either by morphologic criteria or TUNEL positivity), TIA-1-positive lymphocytes, and TIA-1 cap structures (see text). To allow comparison of tissue sections of different shapes and sizes, the quantitative data were normalized to the area of epidermis present in the section, measured from the granular layer to the basement membrane. Means for the allogeneic and autologous BMT groups were compared by the two-tailed t-test for independent samples using the computer program Statistica (StatSoft, Tulsa, OK, USA). Linear regression analysis was performed using the multiple regression module of the same program.
Results
Histologic features
Skin biopsies from autologous and allogeneic BMT recipients were evaluated for the presence of dermal inflammation, epidermal inflammation, vacuolation, spongiosis, apoptotic keratinocytes, bullae formation and epidermal sloughing. The biopsies were then graded for the presence of acute GVHD (Table 1 ) using published criteria. 12 The biopsies from allogeneic BMT patients exhibited much more significant dermal and epidermal inflammation than did the autologous BMT recipients, who generally had only mild perivascular inflammation of the dermis. Consistent with this, secondary inflammatory changes, such as vacuolation, spongiosis, apoptotic keratinocytes, and bullae formation were much more common in the allogeneic BMT group. Secondary inflammatory changes in the autologous BMT group were mainly limited to vacuolation, with only three patients exhibiting mild spongiosis. Satellitosis (one or more lymphocytes in intimate contact with an apoptotic keratinocyte) was much more frequent in the allogeneic group, being seen in eight of 17 biopsies, vs only one of 14 in the autologous group (P = 0.01). The histologic findings were reflected in the GVHD grading of the two groups, which averaged 1.69 for the allogeneic group, vs 0.73 for the autologous group (P = 0.02).
Immunoperoxidase and quantitative studies
Immunoperoxidase studies were performed to detect lymphocytes, macrophages, and the subset of lymphocytes expressing TIA-1, a 15 kDa protein associated with the lytic granules of CTL. Positive cells were counted, and the total normalized to the area of epidermis present in the section. The results for individual patients are shown in Table 361  Table 1 Patient clinical and skin biopsy data Tissue sections were stained with the appropriate antibodies as described in Materials and methods, and the number of positively stained cells counted. To allow comparison of tissue sections of different shapes and sizes, the quantitative data were normalized to the area (in mm 2 ) of epidermis present in the section, measured from the granular layer to the basement membrane. Cy = cytoxan; Bu = busulfan; TBI = total body irradiation; NHL = non-Hodgkin's lymphoma; AA = apalastic anaemia; LG = lymphomatoid granulomatosis; HD = Hodgkin's disease. 1 , and summarized for the autologous and allogeneic BMT groups in Table 2 . In both groups, all parameters measured showed marked variation between individual patients. None of the parameters measured in the dermis (macrophages, total lymphocytes or TIA-1 positive lymphocytes) differed significantly between the allogeneic and autologous groups. In the epidermis, there was a trend for increased numbers of inflammatory cells in biopsies from allogeneic transplant recipients, although only the number of macrophages reached borderline statistical significance. There was also a trend for increased lymphocytes in the epidermis of allogeneic transplant recipients, but the percentage of total lymphocytes expressing TIA-1 did not differ between the two groups.
There were two features which differed significantly between the allogeneic and autologous transplant groups. First, there was a marked increase in the allogeneic group of the percentage of TIA-1 cells showing 'cap structures'; that is, cells in which the TIA-1 antigen was situated in a polar cap-like area near the surface membrane.
11 Polarization of lytic granules to one end of cytotoxic cells has been well documented, [13] [14] [15] and is thought to represent lymphocytes in the process of attack. 16 TIA-1 expression has previously been shown to follow the same distribution during CTL attack. 17 Second, apoptotic keratinocytes were much more frequent in the allogeneic group than the autologous group. At least a portion of the apoptotic keratinocytes in the allogeneic group appeared to result from attack by CTL, because occasional CTL expressing the granule-associated molecule TIA-1 were seen directly adjacent to keratinocytes. These CTL showed polarization toward the target cells, consistent with previous reports by Sale et al. 16 Interestingly, some of the targeted keratinocytes appeared to contain TIA-1 within their cytoplasm (Figure 1) , consistent with the hypothesis that some keratinocyte damage in GVHD results from direct CTL attack. The targeted keratinocytes showed morphologic changes consistent with apoptosis, including cell shrinkage and chromatin condensation. No similar CTL-keratinocyte interactions were detected in the autologous transplant group.
The morphologic changes shown by dying keratinocytes 362 2 ) of epidermis present in the section, measured from the granular layer to the basement membrane. Means for the allogeneic and autologous BMT groups were compared by the two-tailed t-test for independent samples using the computer program Statistica.
through routine histochemical staining have been described by pathologists for many years, often by the term 'dyskeratosis'. 18 These changes appear to be quite sensitive and specific for keratinocyte death, since dyskeratosis is an important diagnostic criterion for GVHD. 18 Recently, Langley et al 19 have shown by TUNEL assay that the keratinocyte death during dyskeratosis is apoptotic in nature, characterized by DNA fragmentation. Since the TUNEL might be more sensitive than morphologic changes for the detection of apoptosis, we performed TUNEL staining on our specimens and quantitated the results. The TUNEL results correlated very strongly with the results by morphologic changes (Figure 2 , r = 0.71, P = 0.00002). The TUNEL assay, as expected, was somewhat more sensitive than morphologic criteria for the detection of keratinocyte apoptosis, generally showing almost 2. times more apoptotic cells. However, the morphologic detection of apoptosis appeared to be more specific, because many TUNEL sections showed significant artifact. The TUNEL sections required careful interpretation based on factors such as the uniformity of staining of large areas of sections (suggesting artifact) vs morphology of TUNEL-positive cells (suggesting apoptosis).
Because there was marked heterogeneity among patients in both the allogeneic and autologous groups, we sought to determine whether there was any relationship between apoptotic keratinocytes and infiltration by immune cells. For recipients of allogeneic BMT, an increase in epithelial lymphocytes correlated with increased apoptotic keratinocytes (Figure 3a , r = 0.57, P = 0.02). A similar correlation was seen between apoptotic keratinocytes and epidermal infiltration by macrophages (Figure 3b , r = 0.62, P = 0.01). Two patients were exceptions to these relation- ships. One of these patients showed large numbers of apoptotic keratinocytes with very little lymphocyte or macrophage infiltration. The keratinocyte apoptosis in this patient probably represents a response to non-immune cellular injury, such as that due to pre-transplant conditioning. Interestingly, the other exceptional patient in the allogeneic group showed large numbers of epithelial lymphocytes and macrophages without any evidence of keratinocyte apoptosis.
Because the percentage of lymphocytes showing TIA-1 caps was significantly higher in recipients of allogeneic transplants (Table 2) , we investigated whether the number of TIA-1 caps correlated with keratinocyte apoptosis. Although these parameters showed a moderate correlation (r = 0.48, P = 0.06), the correlation was weaker than that between apoptosis and epithelial lymphocytes, suggesting that the presence of TIA-1 caps did not predict keratinocyte apoptosis independently of total lymphocyte infiltration.
In contrast to the allogeneic group, there was no relationship in the autologous group between keratinocyte apoptosis and the numbers of total epithelial lymphocytes ( Figure 3c , r = 0.10, P = 0.73), epithelial macrophages (r = 0.13, P = 0.68) or TIA-1 caps (r = 0.13, P = 0.66). One patient had large numbers of apoptotic keratinocytes without any CTL showing TIA-1 caps, similar to patients in the allogeneic group. In addition, several autologous BMT recipients showed large numbers of lymphocytes and TIA-1 caps in the absence of apoptotic keratinocytes. Only two patients in the autologous BMT group had both TIA-1 caps and apoptotic keratinocytes. The number of epithelial lymphocytes or TIA-1 caps and apoptotic keratinocytes in these patients was quite low in comparison with patients in the allogeneic BMT group (Figure 3d ).
Discussion
The skin and other manifestations of acute GVHD following allogeneic BMT are thought to result from the transfer of immunocompetent cells from a donor to an MHC-mismatched recipient who is incapable of rejecting them. A clinically and histologically similar condition is seen in 5-10% of patients undergoing autologous BMT, and has been termed 'autologous GVHD'. Autologous GVHD is thought to result from disruption of the normal immune regulatory mechanisms governing self/nonself recognition. 20, 21 The target tissue damage in both types of GVHD was originally assumed to result from direct attack by CTL. [22] [23] [24] [25] [26] However, recent attention has focused on the role of dysregulated cytokine release (the so-called 'cytokine storm') as the mediator of tissue damage. 27, 28 Whether induced by cytokines or CTL, the tissue damage of GVHD can result in apoptosis, or programmed cell death, of individual cells. The presence of these apoptotic keratinocytes, also known as dyskeratotic bodies, has been used as a diagnostic criterion for GVHD. 6, 7 One of the mechanisms by which CTL induce damage to their target cells is by using components of their lytic granules. The granules contain perforin, which forms membrane pores, allowing entry into the relevant cell compartments by other components of the lytic granule, such as granzymes A and B. 29 The granzymes activate proteins of the regulatory caspase cascade, and cause apoptosis of the target cell. A convenient immunohistologic marker for lytic granules in CTL is the monoclonal antibody recognizing TIA-1, which is localized to the membranes of the lytic granules. In contrast to the granzymes, it is unclear whether TIA-1 plays any direct role in the induction of apoptosis by CTL. Early experiments demonstrated that TIA-1 could induce DNA fragmentation, one of the hallmarks of apoptosis, in permeabilized thymocytes. 30 Later reports, however, demonstrated that the antibody to TIA-1 actually recognized more than one molecule, and that the RNAbinding molecule p40-TIA-1 was distinct from the p15-TIA-1 molecule found on the granule membranes of CTL. 17 The story has become even more complex with the demonstration that both p15-TIA-1 and p40-TIA-1 are phosphorylated by fas-activated serine/threonine kinase (FAST), a molecule involved in the pathway of fas-induced apoptosis. 31 Our results, showing apparent TIA-1 staining within keratinocytes under CTL attack, raise the intriguing possibility that CTL inject a substrate for FAST, p15-TIA-1, as part of their effector mechanism. Additional studies will be necessary to evaluate this possibility. In the present study, however, positivity for TIA-1 was used only as a marker for the lytic granules of activated CTL. 11 Since the other components of the lytic granules of CTL are known to induce apoptosis in target cells, 29 a direct role for TIA-1 in the induction of apoptosis is not necessary to conclude that at least some of the keratinocyte damage in GVHD may be mediated by the direct attack of CTL.
More recently, increasing attention has been paid to the importance of cytokine release as a mechanism of tissue damage in GVHD (reviewed in Ref. 32 ). Tissue damage from conditioning regimens has been suggested to release inflammatory cytokines such as TNF-␣ and IL-1. 27, 28 This leads in turn to up-regulation of HLA and important adhesion molecules. In autologous transplants, this process is self-limited and usually resolves in 7 to 10 days. However, in allogeneic transplants, the up-regulation of HLA can lead to activation of donor T cells, starting a self-perpetuating cascade of cytokine release. Some of the released cytokines, such as TNF-␣ and IL-1, may have direct cytotoxic effects on recipient tissues. Other released cytokines, such as IL-2, may act to amplify the escalating cytokine response, and also to promote direct CTL attack on recipient tissues.
Some of the findings presented in this study, such as the satellitosis and apparent injection of granule components into apoptotic keratinocytes, suggest an important role for direct CTL attack in the damage to host tissues in GVHD. However, other observations suggest that direct CTL attack does not explain all the pathology seen. First, although injection of granule components (TIA-1) into keratinocytes was noted in several allogeneic BMT recipients, the correlation of TIA-1 caps with apoptosis was weaker than the association of total epidermal lymphocytes with apoptosis. This suggests that these lymphocytes use other mechanisms, in addition to direct attack, to cause tissue damage. Second, while several allogeneic recipients showed significant keratinocyte apoptosis in the absence of TIA-1 caps, only one recipient showed keratinocyte apoptosis in the absence of epidermal lymphocyte infiltration. This patient's pathology may represent the results of the pretransplant conditioning regimen.
As a physiologic process, apoptosis is not limited to GVHD, but occurs in a wide variety of situations. Numerous processes can result in the appearance of apoptotic bodies in the skin. The cases presented in this study showing skin pathology in the absence of immune infiltration suggest that the apoptotic keratinocytes seen after bone marrow transplant can result from either the immune attack of GVHD, or the effects of conditioning regimens. Conditioning regimens such as total body irradiation or chemotherapy cause cellular injury to various body tissues and organs, including the skin, resulting in the induction of apoptosis in a subset of keratinocytes.
Apoptotic keratinocytes were present in recipients of autologous BMT, most of whom would not be expected to mount an immune attack against 'self' keratinocytes. Consistent with this expectation, there was no evidence of CTL attack on keratinocytes in the autologous BMT group (satellitosis was rare, lymphocyte infiltration of the epidermis was minimal, and no evidence of CTL injection of TIA-1 into keratinocytes was seen). In fact, only two autologous BMT recipients showed both TIA-1-capped CTL and apoptotic keratinocytes, and the numbers of both were quite low in comparison with allogeneic BMT recipients. These two patients could represent mild 'autologous GVHD', which is generally less severe than allogeneic GVHD. 33 Similarly, one autologous BMT recipient showed increased keratinocyte apoptosis in the presence of increased epidermal lymphocytes, suggesting a possible cytokine-mediated autologous GVHD. We interpret the apoptotic keratinocytes in the other autologous BMT recipients (who had few epidermal lymphocytes and no TIA-1 caps) to represent the effects of conditioning regimens. In contrast, the apoptotic keratinocytes in allogeneic BMT recipients represent the summed effects of conditioning regimens, plus the effects of immune attack in GVHD. In support of this interpretation, lymphocytes were markedly increased, satellitosis was frequent, and CTL injection of TIA-1 into keratinocytes was present. In addition, in the allogeneic BMT group, the number of epidermal lymphocytes correlated with the number of apoptotic keratinocytes.
We found it interesting that the total number of epidermal lymphocytes expressing TIA-1 did not differ between the autologous and allogeneic groups, and yet TIA-1 'cap structures' were much more frequent in the allogeneic BMT recipients. TIA-1 has been shown to be expressed on unstimulated or resting CTL, 10, 34 although its expression is increased upon CTL activation. 35 Our observation of plentiful lymphocytes expressing TIA-1 in autologous BMT recipients supports the idea of 'constitutive' expression. On the other hand, 'capping' of TIA-1 in CTL was much more frequent in allogeneic BMT recipients, supporting the idea that capping occurs only during attack by CTL. TIA-1 positivity within apoptotic keratinocytes was seen exclusively in the allogeneic group, consistent with the notion that injection of granule components occurs only when CTL encounter target cells bearing the appropriate antigens, in this case major or minor histocompatibility antigens. Nevertheless, the correlation between TIA-1 caps and apoptosis was weaker than the correlation between total epidermal lymphocytes and apoptosis, suggesting that direct CTL attack may play a relatively lesser role in the immunopathology of GVHD. Studies in mice suggest that both CTL-dependent and -independent mechanisms are operative in murine GVHD, 36, 37 and additional studies will be required to answer this question conclusively in humans.
Another interesting finding was the presence of CTL with TIA-1 caps in the absence of apoptotic keratinocytes. This situation was more common in autologous BMT recipients, although it was also seen in one patient after allogeneic BMT. It is possible that keratinocyte apoptosis is occurring in these patients, but at a low enough level to not be detected by routine histology or TUNEL staining. Since apoptotic cells are quickly cleared by phagocytosis, 38 visualization of apoptotic cells in tissue sections by either method usually underestimates the total apoptosis occurring. Alternatively, the induction of apoptosis by the capped CTL might be regulated by a mechanism not yet understood. Since autologous GVHD is thought to represent a failure of immune regulation, the finding of TIA-1 caps in the absence of keratinocyte apoptosis may reflect successful control of self-reactive CTL. Finally (although we do not favor this hypothesis), it remains possible that TIA-1 caps are irrelevant in the induction of keratinocyte apoptosis, and serve only as a marker of immune activation.
The effects of pre-BMT conditioning are thought to be most pronounced in the first 20 days post-treatment. 4, 5 However, in this study one autologous BMT recipient continued to show apoptotic keratinocytes at least 26 days after transplant. In this patient, there was no evidence of immune attack (no epidermal lymphocytes, no TIA-1 caps, no satellitosis), suggesting that the effects of conditioning regimens can sometimes last beyond 20 days. Others have shown that skin pathology secondary to conditioning regimens can be seen 4 weeks to 6 months post-transplant, 39 allowing significant overlap with skin pathology due to GVHD. The results of the present study suggest that apoptotic keratinocytes arise in the skin of BMT recipients secondary to both GVHD and conditioning effects. The results also suggest that both cytokine storm and direct CTL attack play a role in the immunopathology of GVHD, and hint that direct attack by CTL may be relatively less important. From a diagnostic viewpoint, increased numbers of apoptotic keratinocytes, in the presence of increased epidermal lymphocytes or 'capped' TIA-1-expressing lymphocytes, support the diagnosis of GVHD, but must be interpreted in the context of clinical information and other histopathologic findings.
